This inventor holds 3 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1998-2005.
Company Filing History:
Years Active: 1998-2005
Title: Scott P. Salowe: Innovator in Biochemical Assays
Introduction
Scott P. Salowe is a notable inventor based in Dayton, NJ (US), recognized for his contributions to the field of biochemical assays. With a total of 3 patents to his name, he has made significant advancements in the understanding and measurement of lethal factors in various biological contexts.
Latest Patents
Salowe's latest patents include innovative methods and substrates for assaying Bacillus anthracis lethal factor protease. The first patent features a lethal factor substrate that can be utilized to measure lethal factor activity. These substrates are designed to contain one or more detectable labels and exhibit a sufficiently high turnover rate for applications in high throughput screening. His second patent describes a high throughput assay for screening compounds capable of binding to a fusion protein, which consists of a target protein and an FK506-binding protein. This application also details the method for preparing the DNA encoding for the fusion protein and for expressing that DNA, along with the recombinant DNA and protein sequences for several fusion proteins.
Career Highlights
Scott P. Salowe is currently employed at Merck & Co., Inc., where he continues to push the boundaries of innovation in his field. His work has been instrumental in developing new methodologies that enhance the efficiency and accuracy of biochemical assays.
Collaborations
Some of his notable coworkers include Alice Marcy and Douglas Wisniewski, who have collaborated with him on various projects within the company.
Conclusion
Scott P. Salowe's contributions to the field of biochemical assays through his patents and work at Merck & Co., Inc. highlight his role as an influential inventor. His innovative approaches continue to impact the scientific community positively.